Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Kidney problems news

Show

From To
Tenofovir, atazanavir/ritonavir and Kaletra associated with kidney problems in patients taking HIV therapy

Data from a large study into the safety of anti-HIV drugs suggest that the antiretrovirals tenofovir (Viread, also in Truvada, Atripla and Eviplera), atazanavir (Reyataz) and lopinavir/ritonavir

Published
15 February 2013
By
Michael Carter
Tenofovir May Raise Risk of Kidney Damage, but Effect Tapers Over Time

Tenofovir raises the risk of kidney dysfunction among people with HIV, but the adverse effect occurs mostly within the first two years of therapy.  

Published
14 February 2013
From
AIDSMeds
Kidney disease in HIV-Infected Patients: Guideline and Commentary

The New York State Department of Health AIDS Institute has issued timely new guidelines on kidney disease in HIV-infected adults. Key points emphasize the importance of informing and educating HIV-infected patients about the increased risk for kidney disease; routinely assessing kidney function in HIV-infected patients; recommending earlier antiretroviral therapy (ART) initiation to patients with HIV-associated nephropathy; and assessing ART medication dosages, as well as other medications, when a patient's GFR reaches ≤ 50 mL/min.

Published
17 October 2012
From
Medscape (requires registration)
More HIV-Positive Patients Receive Organ Transplants

Hospitals are increasingly willing to transplant vital and scarce organs into people who have HIV, a once-unthinkable step now made possible with drug regimens that are helping such patients live longer.

Published
12 October 2012
From
Wall Street Journal
Obesity is a risk factor for co-occuring chronic health problems in patients with HIV

Obesity is associated with the clustering of multiple health problems in HIV-positive people, investigators from the US report in the online edition of the Journal of Acquired Immune

Published
10 October 2012
By
Michael Carter
Starting HIV treatment reduces the risk of serious non-AIDS-related diseases

Serious non-AIDS-defining illnesses are common in people recently diagnosed with HIV, Spanish investigators report in the online edition of AIDS. “Clinicians should be aware that during the initial

Published
09 October 2012
By
Michael Carter
Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

An integrated analysis of data from phase II and III trials showed that the 'Quad' single-tablet regimen has antiviral efficacy at least as good as comparison regimens

Published
12 September 2012
By
Liz Highleyman
Chronic hepatitis C virus infection increases risk of death from both liver disease and non-liver-related causes

As well as increasing the risk of death from liver disease, chronic hepatitis C virus infection increased the risk of death from circulatory and kidney disease

Published
05 September 2012
By
Michael Carter
Atazanavir/ritonavir more likely to cause kidney stones than other ritonavir-boosted protease inhibitors

Treatment with ritonavir-boosted atazanavir is associated with a much higher risk of kidney stones compared to other ritonavir-boosted protease inhibitors, Japanese investigators report in the online edition of

Published
29 August 2012
By
Michael Carter
Starting HIV treatment reduces risk of kidney disease

Starting HIV treatment reduces the risk of chronic kidney disease, US investigators report in the online edition of AIDS. This was especially the case for patients who

Published
23 August 2012
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.